How DarioHealth turned the smartphone into a user-friendly glucose monitor

When DarioHealth (NSDQ:DRIO) CEO Erez Raphael looks at the medical device world, he sees solutions that were designed by healthcare professionals and doctors – and this presents a stark contrast with the consumer device industry, he pointed out. “We have seen there are a lot of cases, most of the cases in the industry, where the […]

Medtronic is closer to VenaSeal coverage: Here’s how

Medtronic is touting its new CPT codes for the VenaSeal varicose vein closure device – codes that company officials think bring the device closer to positive coverage from public and private insurers in the U.S. CMS announced the new codes on Nov. 1 as part of final rules for the 2018 Medicare Physician Fee Schedule (CMS-1676-F)

Medtronic’s CEO thinks value-based care is really important: Here’s why

Value-based care is the future of healthcare, and according to CEO Omar Ishrak, it is the past, present and future of Medtronic. Ishrak spoke at OCTANe’s Medical Technology Innovation Forum (MTIF) this week about the opportunity and responsibility medical device companies have when it comes to adopting value-based care models.  In this future, Ishrak sees

The 10 largest medical device companies in the world

Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their

Pages: 1 2 3 4 5 6 7 8 9 10 11

Medtronic, Mazor Robotics close $40 million round

Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in…

The 10 largest medtech employers – and what their workers really think

Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the

Pages: 1 2 3 4 5 6 7 8 9 10 11

Medtronic recalls insulin infusion sets

Medtronic (NYSE:MDT) said today that it’s recalling some of the infusion sets used with its insulin pumps due to problems with a discontinued component. The Fridley, Minn.-based medical device titan said the problem involves a vent membrane that’s susceptible to blockage during priming and fill-tubing. No pumps or glucose sensors are affected by the recall, Medtronic […]

Webinar: 3D printing at Medtronic – Sept. 5, 2017

Tuesday, September 5, 2017 2:00pm EDT / 11:00am PDT     Learn how 3D printing empowers medical device manufacturer Medtronic to bring products to clinical use faster, develop better therapies and personalize patient care. With functionally accurate, 3D printed prototypes, Medtronic can complete more design revisions in less time, empower physician feedback through an improved

7 ways neurostimulation could make our lives better

Neurostimulation is being used for a lot of different things that go beyond motor disorders and diseases. Neurostimulation is used to stimulate certain parts of the brain’s nervous system. It can be invasive with implants or it can be non-invasive with electrode-filled caps and ear clips. The neurostimulation market was worth an estimated $1.9 billion

Pages: 1 2 3 4 5 6 7 8

What does value mean in healthcare?

“Value” is a word that one hears a lot these days in the medical device industry and healthcare in general, but it’s hard to pin down what it exactly means. Defining what it means matters because public and private healthcare payers in the U.S. and around the world are moving away from traditional fee-for-service payments.

Are we closer to a game-changing device for Parkinson’s disease?

University of Washington researchers say they’ve developed an advanced deep brain stimulation system to treat essential tremor and Parkinson’s without constantly being “on,” allowing for longer battery life and better treatment. The system utilizes electrodes on top of the brain to sense movement in parts of the body that experience essential tremor, alongside a deep

Here are the top 5 medtech stories of mid-2017

The middle of 2017 is shaping up to be a continued whirlwind of activity for medtech. FDA is getting used to its new leadership but is facing a continued lack of clarity on user fees and UDIs. Industry is seeing a deeper consolidation in medical supplies, exemplified in Cardinal Health’s purchase of patient recovery supplies from

Pages: 1 2 3 4 5 6

Cardiology research breakthroughs you need to know

Recent months have seen a host of important cardiology research breakthroughs related to new cardio devices and diagnostics, tissue engineering and the overall understanding of heart disease and its treatment. For example,  a customizable robotic heart sleeve – developed at Harvard University and Boston Children’s Hospital – has demonstrated advantages over other heart assist devices

Medtech stories we missed this week: June 9, 2017

From 3M’s expanded 510(k) clearance for its Tegaderm dressing to Medtronic and Acacia burying the hatchet, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks Taiwanese distro deal for CGuard InspireMD announced in a June 8 press release that it has signed a distribution deal with

Why U.S. first may be the new medical device development strategy

Increased regulatory hurdles in Europe and China could mean more medical device development focusing on the U.S. market first. That seemed to be a major takeaway from panels on regulation and reimbursement at Healthegy’s Medtech Conference, held last week in Minneapolis. “We’re actually going to be doing more early clinical work with the FDA,” said Stacey Pugh, vice